Elevance Health Inc
ELV382.510USD
+10.290+2.76%
Horário de mercado （ET）Cotações atrasadas em 15 min
86.31BValor de mercado
14.43P/L TTM
Mais detalhes de Elevance Health Inc Empresa
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Informações da empresa
Código da empresaELV
Nome da EmpresaElevance Health Inc
Data de listagemOct 30, 2001
Fundado em2001
CEOMs. Gail K. Boudreaux
Número de funcionários103158
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 30
Endereço220 Virginia Avenue
CidadeINDIANAPOLIS
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal46204
Telefone18003311476
Sitehttps://www.elevancehealth.com/
Código da empresaELV
Data de listagemOct 30, 2001
Fundado em2001
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Ryan M. Schneider
Mr. Ryan M. Schneider
Independent Director
Independent Director
--
--
Mr. Peter D. (Pete) Haytaian
Mr. Peter D. (Pete) Haytaian
Executive Vice President and President, Carelon and CarelonRx
Executive Vice President and President, Carelon and CarelonRx
--
--
Mr. Ratnakar V. Lavu
Mr. Ratnakar V. Lavu
Executive Vice President and Chief Digital Information Officer
Executive Vice President and Chief Digital Information Officer
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Ryan M. Schneider
Mr. Ryan M. Schneider
Independent Director
Independent Director
--
--
Detalhamento da receita
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Premiums
144.17B
0.00%
Product revenue
22.63B
0.00%
Service fees
8.41B
0.00%
Reconciliation
1.81B
0.00%
Operating revenue - affliated
0.00
0.00%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Premiums
144.17B
0.00%
Product revenue
22.63B
0.00%
Service fees
8.41B
0.00%
Reconciliation
1.81B
0.00%
Operating revenue - affliated
0.00
0.00%
Acionista
Tempo de atualização: seg, 19 de mai
Tempo de atualização: seg, 19 de mai
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
The Vanguard Group, Inc.
10.13%
BlackRock Institutional Trust Company, N.A.
5.22%
State Street Global Advisors (US)
4.71%
T. Rowe Price Associates, Inc.
3.88%
Wellington Management Company, LLP
2.56%
Other
73.49%
Estatísticas dos acionistas
Acionista
Proporção
The Vanguard Group, Inc.
10.13%
BlackRock Institutional Trust Company, N.A.
5.22%
State Street Global Advisors (US)
4.71%
T. Rowe Price Associates, Inc.
3.88%
Wellington Management Company, LLP
2.56%
Other
73.49%
Tipo
Acionista
Proporção
Investment Advisor/Hedge Fund
41.83%
Investment Advisor
40.93%
Pension Fund
2.50%
Bank and Trust
2.43%
Research Firm
2.01%
Hedge Fund
1.79%
Sovereign Wealth Fund
1.44%
Family Office
0.27%
Family Office
0.27%
Other
6.53%
Participação acionária institucional
Tempo de atualização: dom, 19 de jan
Tempo de atualização: dom, 19 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
3077
213.38M
94.19%
-3.59M
2024Q4
3098
213.30M
93.78%
-5.08M
2024Q3
3004
212.78M
91.75%
-6.27M
2024Q2
2973
214.50M
92.28%
-4.31M
2024Q1
2940
212.64M
91.38%
-6.83M
2023Q4
2879
214.42M
91.26%
-6.60M
2023Q3
2767
215.95M
91.62%
-5.63M
2023Q2
2750
218.40M
92.12%
-4.32M
2023Q1
2729
219.91M
92.66%
-8.42M
2022Q4
2684
220.86M
92.46%
-8.53M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
21.38M
9.45%
+141.85K
+0.67%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
11.78M
5.2%
+200.94K
+1.74%
Dec 31, 2024
State Street Global Advisors (US)
10.68M
4.72%
-5.71K
-0.05%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.24M
4.52%
+459.21K
+4.70%
Dec 31, 2024
Wellington Management Company, LLP
6.36M
2.81%
+1.89M
+42.45%
Dec 31, 2024
Capital International Investors
3.88M
1.71%
+35.58K
+0.93%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.96M
2.19%
+115.97K
+2.39%
Dec 31, 2024
Sanders Capital, LLC
4.69M
2.07%
+76.90K
+1.67%
Dec 31, 2024
Artisan Partners Limited Partnership
2.88M
1.27%
+437.10K
+17.92%
Dec 31, 2024
First Eagle Investment Management, L.L.C.
3.23M
1.42%
+1.04M
+47.56%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: sex, 2 de mai
Tempo de atualização: sex, 2 de mai
Nome
Proporção
iShares U.S. Healthcare Providers ETF
12.36%
T Rowe Price Value ETF
6.18%
Monarch Dividend Plus Index ETF
3.86%
First Eagle Global Equity ETF
3.41%
Brookstone Value Stock ETF
3.3%
GMO US Quality ETF
3.13%
Simplify Market Neutral Equity Long/Short ETF
3.07%
Invesco S&P 500 Enhanced Value ETF
2.61%
NYLI Healthy Hearts ETF
2.6%
T Rowe Price Equity Income ETF
2.43%
Ver Mais
iShares U.S. Healthcare Providers ETF
Proporção12.36%
T Rowe Price Value ETF
Proporção6.18%
Monarch Dividend Plus Index ETF
Proporção3.86%
First Eagle Global Equity ETF
Proporção3.41%
Brookstone Value Stock ETF
Proporção3.3%
GMO US Quality ETF
Proporção3.13%
Simplify Market Neutral Equity Long/Short ETF
Proporção3.07%
Invesco S&P 500 Enhanced Value ETF
Proporção2.61%
NYLI Healthy Hearts ETF
Proporção2.6%
T Rowe Price Equity Income ETF
Proporção2.43%
Dividendo
Um total de
6.19B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
Apr 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Jun 23, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 23, 2023
Jun 08, 2023
Jan 25, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Mar 24, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 24, 2023
Mar 09, 2023
Oct 19, 2022
ELV.NB Final Cash Dividend of gross USD 1.28 paid on Dec 21, 2022 going ex on Dec 02, 2022
Dec 05, 2022
Dec 21, 2022
Dec 02, 2022
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
